| 注册
首页|期刊导航|中国医学创新|坎地沙坦联合贝那普利治疗原发性高血压及其对患者血脂的影响

坎地沙坦联合贝那普利治疗原发性高血压及其对患者血脂的影响

毛志勇

中国医学创新Issue(25):60-61,2.
中国医学创新Issue(25):60-61,2.DOI:10.3969/j.issn.1674-4985.2013.25.028

坎地沙坦联合贝那普利治疗原发性高血压及其对患者血脂的影响

Candesartan Combined with Benazepril Treatment of Essential Hypertension and its Impact on the Blood Lipid

毛志勇1

作者信息

  • 1. 湖南省邵阳市医学高等专科学校附属医院 湖南 邵阳 415000
  • 折叠

摘要

Abstract

Objective:To explore the clinical efficacy of candesartan combined with benazepril to treat hypertension and improve the lipids. Method:118 cases of patients were randomly divided into the experimental group and the control group,the control group was given benazepril treatment,the experimental group was given plus candesartan treatment on the basis of the control group,antihypertensive effect of alterations in lipids, and adverse reactions were compared.Result:Before and after treatment systolic blood pressure,diastolic blood pressure,pulse pressure,blood lipid indexes were significantly lower,the experimental group was significantly better than the control group,the results were statistically significant(P<0.05). Two sets of buck efficiency of 93.2%and 81.4%respectively,results were statistically significant(P<0.05).And the experimental group less adverse reactions,gradually recovered after discontinuation.Conclusion:Candesartan combined with benazepril treat hypertension with good efficacy,little adverse reactions,and can significantly improve the lipids,worthy of promotion.

关键词

坎地沙坦/贝那普利/原发性高血压

Key words

Candesartan/Benazepril/Hypertension

引用本文复制引用

毛志勇..坎地沙坦联合贝那普利治疗原发性高血压及其对患者血脂的影响[J].中国医学创新,2013,(25):60-61,2.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文